These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
334 related articles for article (PubMed ID: 799763)
1. Immunotherapy in malignant melanomaa. Homes EC; Morton DL; Eilber FR; Golub SE; Sulit HL Natl Cancer Inst Monogr; 1976 Nov; 44():85-6. PubMed ID: 799763 [TBL] [Abstract][Full Text] [Related]
2. Surgical treatment of malignant melanoma. Rosenberg SA Cancer Treat Rep; 1976 Feb; 60(2):159-63. PubMed ID: 769968 [TBL] [Abstract][Full Text] [Related]
3. Experience with BCG adjuvant immunotherapy in stage II malignant melanoma. Peter HH; Deutschmann EM; Schultheis W; Deicher H Dev Biol Stand; 1977 Apr 13-15; 38():537-40. PubMed ID: 344106 [TBL] [Abstract][Full Text] [Related]
4. Monitoring immunotherapy with Bacillus Calmette-Guérin by antibody titer. Wile AG; Sparks FC; Morton DL Cancer Res; 1977 Jul; 37(7 Pt 1):2251-6. PubMed ID: 324610 [TBL] [Abstract][Full Text] [Related]
5. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma. Eilber FR; Morton DL; Holmes EC; Sparks FC; Ramming KP N Engl J Med; 1976 Jan; 294(5):237-40. PubMed ID: 1244548 [TBL] [Abstract][Full Text] [Related]
6. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma. Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970 [TBL] [Abstract][Full Text] [Related]
7. In vitro assay of cell-mediated immunity in BCG therapy of malignant melanoma: a preliminary report. Nathanson L; Clark DA Natl Cancer Inst Monogr; 1973 Dec; 39():221-4. PubMed ID: 4595321 [No Abstract] [Full Text] [Related]
9. Adjuvant BCG immunotherapy for stage I and II malignant melanoma. Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739 [TBL] [Abstract][Full Text] [Related]
11. Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine. Hsueh EC; Morton DL Semin Cancer Biol; 2003 Dec; 13(6):401-7. PubMed ID: 15001158 [TBL] [Abstract][Full Text] [Related]
12. Results of adjuvant BCG immunotherapy in malignant melanoma. Wätzig V; Knopf B Arch Geschwulstforsch; 1981; 51(6):493-6. PubMed ID: 7332442 [TBL] [Abstract][Full Text] [Related]
13. [Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy]. Trapeznikov NN; Iavorskiĭ VV; Kadagidze ZG; Malaev SG; Kupin VI Vopr Onkol; 1977; 23(8):27-33. PubMed ID: 906404 [TBL] [Abstract][Full Text] [Related]
14. BCG immunotherapy in patients with malignant melanoma. Karakousis CP; Douglass HO; Yeracaris PM; Holyoke ED Arch Surg; 1976 Jun; 111(6):716-8. PubMed ID: 776125 [TBL] [Abstract][Full Text] [Related]
15. Immune response and non-specific immunotherapy in melanoma. El-Domeiri AA Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492 [TBL] [Abstract][Full Text] [Related]
16. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma. Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036 [TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy. Richman SP; Gutterman JU; Hersh EM Can Med Assoc J; 1979 Feb; 120(3):322-4, 329. PubMed ID: 371776 [TBL] [Abstract][Full Text] [Related]